Hydromer, Inc., a company with over 40 years of experience in hydrophilic, thromboresistant and antimicrobial coating technologies, has announced its expansion into the manufacturing and global supply of automated high-speed coating and UV curing equipment. This strategic move allows the company to provide medical device manufacturers with a comprehensive, end-to-end solution by integrating its proprietary coatings with high-performance machinery.
The importance of this expansion lies in its potential to streamline medical device manufacturing processes while enhancing quality control. By offering both coatings and the equipment to apply them, Hydromer eliminates technical barriers that manufacturers typically face when trying to implement specialized coating technologies. This integrated approach allows manufacturers to correlate process parameters directly with performance outcomes, which is crucial for compliance with ISO 13485 and FDA Quality System Regulations (21 CFR Part 820).
The company's expanded equipment platform includes several key systems designed to improve manufacturing efficiency. The Hydrophilic Coating Equipment delivers uniform coating application and UV curing with minimal manual intervention. The Automated High-Throughput Coating System represents a modular approach comprised of load, dip coating and UV curing workstations that can be operated by a single operator, increasing production rates while reducing reliance on manual labor. Additionally, the Friction Testing Equipment provides precise and repeatable measurements for lubricity tests, supporting performance evaluation and quality control.
Michael Torti, CEO of Hydromer, emphasized the strategic rationale behind this expansion, stating that by manufacturing and supplying the equipment used to apply their industry-leading hydrophilic coatings, the company helps clients reduce time to market while maintaining the highest standards of quality and regulatory confidence. This approach addresses a significant challenge in medical device manufacturing where consistency and compliance are paramount.
The implications of this announcement extend across the medical device industry, potentially affecting how manufacturers approach coating processes. By providing an integrated solution, Hydromer offers manufacturers the opportunity to simplify their supply chains, reduce validation complexity, and potentially accelerate product development cycles. The equipment's design for single-operator functionality could also help address labor challenges in manufacturing environments while maintaining consistent quality output.
For the global medical device industry, this development represents a shift toward more integrated solutions that combine materials science with manufacturing technology. As regulatory requirements continue to evolve and demand for medical devices grows, such comprehensive approaches may become increasingly valuable for manufacturers seeking to maintain competitive advantages while ensuring patient safety and regulatory compliance. The original release can be viewed on www.newmediawire.com.
